Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma

Fig. 4

A risk of three-gene signature predicted the overall survival in patients with LUSC. A, Distribution of risk score per patient; B, Survival status of each patients; C, A heatmap of three genes expression profile; D, Kaplan-Meier survival curve analysis for LUSC patients divided into the high-risk and low-risk groups. Abbreviation: LUSC, lung squamous cell carcinoma

Back to article page